Frontier Medicines is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with debilitating diseases by discovering and developing innovative medicines against previously inaccessible disease-causing proteins. They leverage their proprietary chemoproteomics platform, The Frontier™ Platform, to identify and validate novel druggable binding pockets on these 'undruggable' targets. Their pipeline focuses on oncology and other serious disorders, aiming to deliver breakthrough therapies.
Primary center for research and development, corporate operations, and strategic leadership.
State-of-the-art laboratory facilities designed for advanced chemoproteomics research and drug discovery, located within a prominent biotechnology hub.
A dynamic, science-driven, and collaborative environment focused on innovation, urgency, and a patient-centric approach to drug development.
Strategically positioned in the heart of the Bay Area's biotech ecosystem, facilitating access to talent, collaborations, and industry resources.
Frontier Medicines' primary operational footprint is within the United States, with key sites in South San Francisco, CA, and Boston, MA. While direct international offices are not prominently listed, their global reach is achieved through scientific collaborations, engagement with the international research community, participation in global conferences, and potential for future international clinical trials and partnerships.
230 E Grand Ave
South San Francisco
CA
USA
Address: One Post Office Square, Boston, MA 02109, USA
To leverage the extensive academic, clinical, and biopharmaceutical network in the Boston area, fostering partnerships and talent acquisition.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Frontier Medicines' leadership includes:
Frontier Medicines has been backed by several prominent investors over the years, including:
Over the past 12 months, Frontier Medicines has strategically expanded its leadership team, notably with the appointment of a new Chief Operating Officer, reflecting its growth phase and focus on operational excellence as its pipeline advances. No high-profile executive departures have been publicly announced during this period.
Discover the tools Frontier Medicines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Based on common industry patterns and observed formats for companies of similar size and domain, Frontier Medicines likely utilizes a standard email format. The most probable format is [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com].
flast@frontiermeds.com or first.last@frontiermeds.com
Format
jdoe@frontiermeds.com or jane.doe@frontiermeds.com
Example
80%
Success rate
Frontier Medicines Website • May 20, 2024
Frontier Medicines announced its participation in the Jefferies Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference in June 2024, where company leadership will present updates....more
PR Newswire • April 10, 2024
Frontier Medicines announced the appointment of Scott Clarke as Chief Operating Officer. Mr. Clarke brings over 20 years of experience in biotechnology operations and will contribute to the company's growth and pipeline advancement....more
PR Newswire • January 4, 2024
Frontier Medicines announced the appointment of Paul Lammers, M.D., M.Sc., to its Board of Directors, adding significant clinical development and corporate strategy expertise to the board....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Frontier Medicines, are just a search away.